Select Page

Global Immunoglobulin (IG) Usage & Forecast to 2027

 

AN ANALYSIS OF THE GLOBAL IMMUNOGLOBULIN (IG) MARKET IN 2020
AND FORECAST TO THE YEAR 2027

As immunoglobulin (IG) is the dominant revenue-generating therapeutic protein from plasma fractionation, its future growth rate profoundly impacts the entire industry on a number of levels, including plasma requirements forecasting, plasma collection capacity planning, manufacturing infrastructure planning, projection of per-liter plasma valuation, and revenue and profit forecasting.  For these and other reasons, projection of the likely future demand for IG is of critical importance.

This new report takes a deep look at current IG usage levels around the globe, and details how IG is used by medical specialty and key indications across all five geographic regions (North America, South America, Asia/Pacific, Europe, and the Middle East/Africa).  MRB’s forecast model analyzes both key drivers of IG growth and risks to future growth, taking into account how the interaction of plasma supply and IG demand can be expected to influence price patterns globally over the next 7 years. This report identifies IG usage in over 80 countries in 2019 and 2020, including breakdowns of IVIG and SCIG market shares by geographic region.  For 2021 through 2027, the report forecasts country-level IG product sales in units, and regional sales in both U.S. dollars and average manufacturer-level price per gram.  Also detailed for each region are key growth drivers and expected growth rates by region over the forecast period. The COVID19 pandemic’s effect plasma collections and consequently the supply of IG is heavily discussed as it significantly effects the next few years of sales around the world.

Compared with a few years ago, there is increasing realization that new competition to IG usage in several autoimmune conditions including Myasthenia Gravis, ITP and CIDP is fast approaching. Of important concern among plasma fractionation companies, is the effect that new therapies will have on IG demand in these conditions.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

 

1. INTRODUCTION

2. FORECAST ASSUMPTIONS

3. IMMUNOGLOBULIN USAGE & FORECAST IN NORTH AMERICA

2020 IG Usage in North America
Current IG Usage by Indication in the United States
Neurological IG Usage in the United States
Primary & Secondary Immunodeficiency IG Usage in the United States
Canada Current IG Usage by Indication
Forecast to 2027 in North America
Growth Drivers of IG Usage over Forecast Period

4. IMMUNOGLOBULIN USAGE & FORECAST IN EUROPE

2020 IG Usage in Europe
United Kingdom Current IG Usage by Indication
France Current IG Usage by Indication
Belgium Current IG Usage by Indication
Neurological Immunoglobulin Usage in Europe
Primary Immunodeficiency and Immunoglobulin Usage in Europe
Secondary Immunodeficiency and Immunoglobulin Usage in Europe
Forecast to 2027 in Europe
Growth Drivers of IG Usage over the Forecast Period

5. IMMUNOGLOBULIN USAGE & FORECAST IN ASIA & PACIFIC

2020 IG Usage in Asia Pacific
Australia Current IG Usage by Indication
Chinese IG Usage by Indication
Primary & Secondary Immunodeficiency and Immunoglobulin Usage in Asia Pacific
Neurological and Other Immunoglobulin Usage in Asia Pacific
Forecast to 2027 in Asia Pacific
Growth Drivers of IG Usage over Forecast Period

6. IMMUNOGLOBULIN USAGE & FORECAST IN THE MIDDLE EAST & AFRICA

2020 IG Usage in Middle East & Africa
Primary Immunodeficiency and Immunoglobulin Usage in Africa
Other Immunoglobulin Usage in Latin America
Forecast to 2027 in Middle East & Africa
Growth Drivers of IG Usage over Forecast Period

7. IMMUNOGLOBULIN USAGE & FORECAST IN LATIN AMERICA

2020 IG Usage in Latin America
Primary & Secondary Immunodeficiency and IG Usage in Latin America
Neurological Immunoglobulin Usage in Latin America
Forecast to 2027 in Latin America
Growth Drivers of IG Usage over Forecast Period

8. FORECAST OF THE WORLDWIDE IMMUNOGLOBULIN DEMAND

2020 Global IG Usage
Global IG Forecast from 2020 to 2027
Growth by Year
Average Annual Growth from 2020-2027
IG Growth Expectations by Specialties/Diseases